Home/Pipeline/AiMIFY™

AiMIFY™

Not Specified

Work in ProgressActive

Key Facts

Indication
Not Specified
Phase
Work in Progress
Status
Active
Company

About Subtle Medical

Subtle Medical is a private, commercial-stage company founded in 2017 as a Stanford spin-out, specializing in AI-powered medical imaging enhancement. It has secured 9 FDA clearances for its software suite, which includes SubtleMR™, SubtlePET™, and the integrated Subtle-ELITE™ package for MRI. With over $50M raised and software deployed on nearly a thousand scanners globally, the company aims to improve radiology workflow efficiency, patient throughput, and safety by reducing scan times and contrast agent dosage. Its leadership combines deep technical AI expertise with clinical radiology experience.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved